Safety and efficacy of grazoprevir/elbasvir in the treatment of acute hepatitis C in hemodialysis patients. Ji Q, Chu X, Zhou Y, Liu X, et al. J Med Virol 2021 Oct 2. doi: 10.1002/jmv.27374.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ji Q, Chu X, Zhou Y, Liu X, et al. Safety and efficacy of grazoprevir/elbasvir in the treatment of acute hepatitis C in hemodialysis patients. J Med Virol 2021 Oct 2. doi: 10.1002/jmv.27374.
PMID: 34599755